Patents by Inventor Sandhya S. Rao

Sandhya S. Rao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9561234
    Abstract: Disclosed herein is a method of treating disorders of the retina comprising administering to a patient in need of such treatment a compound selected from the group consisting of olanzapine, certain of its metabolites, clozapine, and n-desmethyl clozapine.
    Type: Grant
    Filed: April 27, 2015
    Date of Patent: February 7, 2017
    Assignee: Allergan, Inc.
    Inventors: Jyotirmoy Kusari, Sheila X. Zhou, Mingting Tian, Edwin U. Padillo, Sandhya S. Rao, Daniel W. Gil, Larry A. Wheeler
  • Publication number: 20150290215
    Abstract: Disclosed herein is a method of treating disorders of the retina comprising administering to a patient in need of such treatment a compound selected from the group consisting of olanzapine, certain of its metabolites, clozapine, and n-desmethyl clozapine.
    Type: Application
    Filed: April 27, 2015
    Publication date: October 15, 2015
    Inventors: Jyotirmoy Kusari, Sheila X. Zhou, Mingting Tian, Edwin U. Padillo, Sandhya S. Rao, Daniel W. Gil, Larry A. Wheeler
  • Patent number: 9018202
    Abstract: Disclosed herein is a method of treating disorders of the retina comprising administering to a patient in need of such treatment a compound selected from the group consisting of olanzapine, certain of its metabolites, clozapine, and n-desmethyl clozapine.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: April 28, 2015
    Assignee: Allergan, Inc.
    Inventors: Jyotirmoy Kusari, Sheila X. Zhou, Mingting Tian, Edwin U. Padillo, Sandhya S. Rao, Daniel W. Gil, Larry A. Wheeler
  • Publication number: 20120142675
    Abstract: Disclosed herein is a method of treating disorders of the retina comprising administering to a patient in need of such treatment a compound selected from the group consisting of olanzapine, certain of its metabolites, clozapine, and n-desmethyl clozapine.
    Type: Application
    Filed: November 16, 2011
    Publication date: June 7, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Jyotirmoy Kusari, Sheila X. Zhou, Mingting Tian, Edwin U. Padillo, Sandhya S. Rao, Daniel W. Gil, Larry A. Wheeler